
|Videos|April 14, 2017
New Parkinson Disease Treatment
Author(s)Bobby Lazzara, MD
Patients with Parkinson disease experiencing “off” episodes on levodopa/carbidopa now have another treatment option.
Advertisement
There is now another option for patients with Parkinson disease. The
In patients experiencing “off” episodes, safinamide has been shown in two clinical trials to be efficacious in reducing involuntary movement and improving motor function scores.
The most common side effects are falls, nausea, insomnia, and dyskinesia.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
NeuroVoices: Benjamin Tolchin, MD, FAAN, on First-Ever AAN Guidelines for Functional Seizures
2
Women Physicians Day 2026: Sex-Specific Clinical Considerations in Women With Epilepsy
3
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
4
Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis
5









